Abstract
Gamma-hydroxybutyrate (GHB) is a drug of abuse, an approved therapeutic for narcolepsy, an agent employed for facilitation of sexual assault, as well as a biomarker of succinic semialdehyde dehydrogenase deficiency (SSADHD). Our laboratory seeks to identify surrogate biomarkers in SSADHD that can shed light on the developmental course of this neurometabolic disease. Since GHB may be quantified in hair as a potential surrogate to identify victims of drug-related assault, we have opted to examine its level in SSADHD. We quantified GHB in hair derived from ten patients with SSADHD, and documented a significant negative age correlation. These findings are consistent with recent results in patient biological fluids, including plasma and red blood cells. These findings may provide additional insight into the developmental course of SSADHD (Jansen et al., J Inherit Metab Dis 39:795–800, 2016).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Absalom N, Eghorn LF, Villumsen IS, Karim N, Bay T, Olsen JV, Knudsen GM, Bräuner-Osborne H, Frølund B, Clausen RP, Chebib M, Wellendorph P (2012) α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB). Proc Natl Acad Sci U S A 109:13404–13409
Ainslie GR, Gibson KM, Vogel KR (2016) A pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS-382 in mouse informs novel therapeutic strategies for the treatment of GHB intoxication. Pharmacol Res Perspect 4(6):e00265
Bertol E, Mari F, Vaiano F, Romano G, Zaami S, Baglìo G, Busardò FP (2015) Determination of GHB in human hair by HPLC-MS/MS: development and validation of a method and application to a study group and three possible single exposure cases. Drug Test Anal 7:376–384
Brenneisen R, Elsohly MA, Murphy TP, Passarelli J, Russmann S, Salamone SJ, Watson DE (2004) Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol 28:625–630
Busardò FP, Vaiano F, Mannocchi G, Bertol E, Zaami S, Marinelli E (2016) Twelve months monitoring of hair GHB decay following a single dose administration in a case of facilitated sexual assault. Drug Test Anal. doi:10.1002/dta.2100 [Epub ahead of print]
Buzzi A, Wu Y, Frantseva MV, Perez Velazquez JL, Cortez MA, Liu CC, Shen LQ, Gibson KM, Snead OC (2006) Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function. Brain Res 1090:15–22
Cooper GAA, Kronstrand R, Kintz P (2012) Society of Hair Testing (SoHT) guidelines for drug testing in hair. Forensic Sci Int 218:20–24
Gibson KM, Jakobs C, Ogier H, Hagenfeldt L, Eeg-Olofsson KE, Eeg-Olofsson O, Aksu F, Weber H-P, Rossier E, Vollmer B, Lehnert W (1995) Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis 18:143–146
Goullé JP, Chèze M, Pépin G (2003) Determination of endogenous levels of GHB in human hair. Are there possibilities for the identification of GHB administration through hair analysis in cases of drug-facilitated sexual assault? J Anal Toxicol 27:574–580
Hillmer AT, Mason GF, Fucito LM, O'Malley SS, Cosgrove KP (2015) How imaging glutamate, γ-aminobutyric acid, and dopamine can inform the clinical treatment of alcohol dependence and withdrawal. Alcohol Clin Exp Res 39:2268–2282
Jagerdeo E, Montgomery MA, LeBeau MA (2015) An improved method for the analysis of GHB in human hair by liquid chromatography tandem mass spectrometry. J Anal Toxicol 39:83–88
Jansen EE, Struys E, Jakobs C, Hager E, Snead OC, Gibson KM (2008) Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development. BMC Dev Biol 8:112
Jansen EE, Vogel KR, Salomons GS, Pearl PL, Roullet J-B, Gibson KM (2016) Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism. J Inherit Metab Dis 39:795–800
Maitre M, Klein C, Mensah-Nyagan AG (2016) Mechanisms for the specific properties of γ-hydroxybutyrate in brain. Med Res Rev 36:363–388
Malaspina P, Roullet JB, Pearl PL, Ainslie GR, Vogel KR, Gibson KM (2016) Succinic semialdehyde dehydrogenase deficiency (SSADHD): pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism. Neurochem Int 99:72–84
Parviz M, Vogel K, Gibson KM, Pearl PL (2014) Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies. J Pediatr Epilepsy 3(4):217–227
Pearl PL, Gibson KM, Quezado Z, Dustin I, Taylor J, Trzcinski S, Schreiber J, Forester K, Reeves-Tyer P, Liew C, Shamim S, Herscovitch P, Carson R, Butman J, Jakobs C, Theodore W (2009) Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 73:423–429
Reis J, Cohen LG, Pearl PL, Fritsch B, Jung NH, Dustin I, Theodore WH (2012) GABAB-ergic motor cortex dysfunction in SSADH deficiency. Neurology 79:47–54
Shi Y, Cui X, Shen M, Xiang P (2016) Quantitative analysis of the endogenous GHB level in the hair of the Chinese population using GC/MS/MS. J Forensic Leg Med 39:10–15
Staeheli SN, Baumgartner MR, Gauthier S, Gascho D, Jarmer J, Kraemer T, Steuer AE (2016) Time-dependent postmortem redistribution of butyrfentanyl and its metabolites in blood and alternative matrices in a case of butyrfentanyl intoxication. Forensic Sci Int 266:170–177
Talaei SA, Azami A, Salami M (2016) Postnatal development and sensory experience synergistically underlie the excitatory/inhibitory features of hippocampal neural circuits: glutamatergic and GABAergic neurotransmission. Neuroscience 318:230–243
Vogel KR, Ainslie GR, Gibson KM (2016) mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism. J Inherit Metab Dis 39:877–886
Wang X, Linnet K, Johansen SS (2016) Development of a UPLC–MS/MS method for determining γ-hydroxybutyric acid (GHB) and GHB glucuronide concentrations in hair and application to forensic cases. Forensic Toxicol 34:51–60
Acknowledgements
The authors gratefully acknowledge the patients and families who contributed hair samples for this study. The ongoing support of the SSADH association (www.ssadh.net) and Speragen, Inc., for longitudinal analyses of patient biological samples, is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Jaak Jaeken, Em. Professor of Paediatrics
Appendices
Author Contributions
-
JSS, WX, SPD: acquisition and analysis of data
-
PLP, JBR, KRV, GRA: conception and design of study; drafting of manuscript
-
KMG: conception and design of study; data analysis; manuscript drafting
Conflicts of Interest
The authors cumulatively declare they have no direct or perceived conflicts of interest.
Guarantor
K. M. Gibson.
Details of Funding
Described in acknowledgements.
Ethics Approval
Approved by WSU IRB (Institutional Review Board for Human Studies).
Rights and permissions
Copyright information
© 2017 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Johansen, S.S. et al. (2017). Gamma-Hydroxybutyrate (GHB) Content in Hair Samples Correlates Negatively with Age in Succinic Semialdehyde Dehydrogenase Deficiency. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 36. JIMD Reports, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2017_3
Download citation
DOI: https://doi.org/10.1007/8904_2017_3
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56137-9
Online ISBN: 978-3-662-56138-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)